/Companies

Algiax

Erkrath, DE · 2 known investors

Find your way into Algiax

Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need. The company's lead candidate AP-325 is in Phase 2 clinical trials for chronic neuropathic pain.

Founders & leadership

DG
Dr. Guido KoopmansChief Scientific Officer
DB
Dr. Birgit HasseHead of CMS and Regulator Affairs

Investors · 2

Frequently asked questions

What does Algiax do?
Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need. The company's lead candidate AP-325 is in Phase 2 clinical trials for chronic neuropathic pain.
Who are Algiax's investors?
Algiax's investors include OCCIDENT, KfW.
Where is Algiax headquartered?
Algiax is headquartered in Erkrath, DE.